newsfilter
← Latest News
PR Newswire·

Iroquois Capital Delivers Open Letter to PharmaCyte Biotech Board of Directors

Expresses Disappointment in the Board's Failure to Articulate a Plan to Maximize Shareholder Value Amid Prolonged Product Development Efforts Despite the Company's Strong Cash Position Criticizes the Company's Dismal Efforts to Communicate with Shareho